| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 11/25/2010 | US20100297026 Imaging of Activated Vascular Endothelium Using Immunomagnetic MRI Contrast Agents |
| 11/25/2010 | US20100297025 Novel compositions magnetic particles covered with gem-bisphosphonate derivatives |
| 11/25/2010 | US20100297024 Promoter inducible by reactive oxygen species and vector comprising the same |
| 11/25/2010 | US20100297023 Lipid |
| 11/25/2010 | US20100297022 Magnetosome Gene Expression in Eukaryotic Cells |
| 11/25/2010 | US20100297021 Variants of C-Type Natriuretic Peptide |
| 11/25/2010 | US20100297020 Phosphorylated and phosphonated pyrone analogs for therapeutic treatment |
| 11/25/2010 | US20100297019 Particles for imaging |
| 11/25/2010 | US20100297018 Prognosis and therapy of liver failure |
| 11/25/2010 | US20100297017 Method for Synthesizing and Using Pegylated Peptide-Photoactive Chromophore Conjugates and Micellular Formulations Thereof |
| 11/25/2010 | US20100297016 Quarternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids |
| 11/25/2010 | US20100297015 Cancer biomarker and uses thereof |
| 11/25/2010 | US20100297014 Method of detecting the risk of cancer using genetic markers |
| 11/25/2010 | US20100297013 Humanized antibody |
| 11/25/2010 | US20100297012 Humanized antibody |
| 11/25/2010 | US20100297011 Isolated peptides and uses thereof |
| 11/25/2010 | US20100297010 Tumor suppressor gene screening using rna interference libraries and method of treatment |
| 11/25/2010 | US20100297009 Self-assembled polyhedral multimeric chemical structures |
| 11/25/2010 | US20100297008 Ganglioside associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumors |
| 11/25/2010 | US20100297007 Ligand directed toroidal nanoparticles for therapy and diagnostic imaging |
| 11/25/2010 | US20100297006 NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 191P4D12(b) USEFUL IN TREATMENT AND DETECTION OF CANCER |
| 11/25/2010 | US20100297004 High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection |
| 11/25/2010 | US20100297003 Anti-human tenascin monoclonal antibody |
| 11/25/2010 | CA2800371A1 Methods of renal cancer detection |
| 11/24/2010 | EP2253956A2 Immune response assessment method |
| 11/24/2010 | EP2253333A2 Contrast Agents for Myocardial Perfusion Imaging |
| 11/24/2010 | EP2253332A2 Low osmolar x-ray contrast media formulations |
| 11/24/2010 | EP2253308A1 Pharmaceutical composition comprising microbubbles for targeted tumor therapy |
| 11/24/2010 | EP2252901A1 System and method for magnetic resonance imaging |
| 11/24/2010 | EP2252729A1 Biomarkers for head-and-neck cancers and precancers |
| 11/24/2010 | EP1355919B1 Molecules with extended half-lives, compositions and uses thereof |
| 11/24/2010 | EP1119371B1 Flt4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY |
| 11/24/2010 | EP0444181B2 C-erbb-2 external domain: gp75 |
| 11/24/2010 | CN1929869B Phospholipid analogs as diagnostic and therapeutic agents for numerous cancers |
| 11/24/2010 | CN1929868B Lyposome-containing x ray-imaging agent and method for producing the same |
| 11/24/2010 | CN101896208A Fluorescent marker for cell death in the eye |
| 11/24/2010 | CN101896203A Use of 5-aminolevulinic acid and derivatives in a solid form for photodynamic treatment and diagnosis |
| 11/24/2010 | CN101896119A Uridine dietary supplementation compliance methods and use thereof |
| 11/24/2010 | CN101891897A Method for preparing paramagnetic polyphosphazene nanotube magnetic resonance imaging contrast agent |
| 11/24/2010 | CN101891696A Poly-iodo acromatic compound and preparation method and application thereof |
| 11/24/2010 | CN101891680A Modulators of atp-binding cassette transporters |
| 11/24/2010 | CN101890173A Preparation method of magnetic resonance imaging contrast agent of magnetic water-soluble chitosan |
| 11/23/2010 | US7838726 useful for screening potential drugs for toxicity toward introduced cells or for capacity to stimulate differentiation and/or proliferation of introduced cells; diagnosing the presence of small quantities of cancerous cells or pathogens in patient tissue samples |
| 11/23/2010 | US7838699 Embolization using degradable crosslinked hydrogels |
| 11/23/2010 | US7838557 treating an allergic reaction by topically administering a therapeutically effective amount of an X-ray contrast medium comprising a triiodinated benzene moiety that is completely or partially substituted, and where contrast medium is a non-ionic or ionic monomer, a non-ionic or ionic dimer |
| 11/23/2010 | US7838531 Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis |
| 11/23/2010 | US7837981 Methods for imaging soluble A-beta |
| 11/23/2010 | CA2569134C Ultrasound contrast agent dosage formulation |
| 11/23/2010 | CA2503223C Meso-substituted porphyrins |
| 11/23/2010 | CA2315271C Platelet derived growth factor (pdgf) nucleic acid ligand complexes |
| 11/18/2010 | WO2010132474A2 Stable elastomeric negative acoustic contrast particles and their use in acoustic radiation fields |
| 11/18/2010 | WO2010132471A2 Synthesis of stable elastomeric negative acoustic contrast particles |
| 11/18/2010 | WO2010130814A1 Method for preparing a pharmaceutical formulation of lanthanide chelate in powder form |
| 11/18/2010 | WO2010130365A2 Use of high-doses of monomeric contrast medium containing iodine in x-ray diagnostics, in particular in interventional x-ray diagnostics and in radiation therapy assisted by contrast media containing iodine |
| 11/18/2010 | WO2010096733A3 Luminescent porous silicon nanoparticles, methods of making and using same |
| 11/18/2010 | WO2010007329A3 Novel method for measuring insulin resistance |
| 11/18/2010 | US20100291577 Toll-Like Receptor 9 Modulators |
| 11/18/2010 | US20100291001 Metalloproteinase-binding proteins |
| 11/18/2010 | US20100291000 Diagnostic value of systemic ACE pathway activation in the detection by fluorescence of localized pathological lesions |
| 11/18/2010 | US20100290999 Nanoparticles of light emissive polymers and preparation method thereof |
| 11/18/2010 | US20100290998 Methods of preventing ischemic injury using peripheral nociceptive stimulation |
| 11/18/2010 | US20100290997 Imaging Agents and Methods |
| 11/18/2010 | US20100290996 Methods and compositions based on culturing microorganisms in low sedimental fluid shear conditions |
| 11/18/2010 | US20100290995 Radio-opaque compounds, compositions containing same and methods of their synthesis and use |
| 11/18/2010 | US20100290994 O-Methylated Rapamycin Derivatives For Alleviation And Inhibition Of Lymphoproliferative Disorders |
| 11/18/2010 | US20100290993 Antibodies to IL-6 and use thereof |
| 11/18/2010 | US20100290992 Nanoparticle nucleic acid binding compound conjugates forming i-motifs |
| 11/18/2010 | US20100290990 Method for preparing a marked purine derivative, said derivative and uses thereof |
| 11/18/2010 | US20100290989 Compositions affecting hyaluronic acid mediated activity |
| 11/18/2010 | US20100290986 Therapeutic use of diaminophenothiazines |
| 11/18/2010 | US20100290985 Macromolecular compositions that cross the blood-brain barrier and methods of use thereof |
| 11/18/2010 | US20100290984 Anti-mrp3 antibodies and methods of use |
| 11/18/2010 | DE102009021752A1 Verwendung monomerer iodhaltiger Kontrastmittel in hohen Dosierungen für Röntgendiagnostik, insbesondere für die intraventionelle Using monomeric iodinated contrast media in high dosages of Radiology, especially for the intraventionelle |
| 11/18/2010 | CA2761646A1 Use of high-doses of monomeric contrast medium containing iodine in x-ray diagnostics, in particular in interventional x-ray diagnostics and in radiation therapy assisted by contrast media containing iodine |
| 11/17/2010 | EP2251695A2 Markers associated with endometrial disease |
| 11/17/2010 | EP2251694A1 Kit for detecting cancer cells metastasizing into sentinel lymph node |
| 11/17/2010 | EP2251044A1 Method and system for determining whether a drug will be effective on a patient with a disease |
| 11/17/2010 | EP2251043A2 Nanoparticles of light emissive polymers and preparation method thereof |
| 11/17/2010 | EP2251042A2 Method of optimizing the treatment of philadelphia-positive leukemia with abl tyrosine kinase inhibitors |
| 11/17/2010 | EP2251041A2 Intramolecularly-quenched near infrared fluorescent probes |
| 11/17/2010 | EP2250504A2 Use of fsh receptor ligands for diagnosis and therapy of cancer |
| 11/17/2010 | EP2250190A1 Optimized adhesin fragments and corresponding nanoparticles |
| 11/17/2010 | EP1476428B1 Pyridyl sulfone derivatives as 5-ht6 receptor ligands |
| 11/17/2010 | EP1027080B1 Method for detection of fibrin clots |
| 11/17/2010 | CN101888992A Contrast agents |
| 11/17/2010 | CN101888858A Contrast agents |
| 11/17/2010 | CN101888857A Polymeric drug carrier for image-guided delivery |
| 11/17/2010 | CN101885913A Nanoparticles of light emissive polymers and preparation method thereof |
| 11/17/2010 | CN101885736A 5-aminolevulinic acid phosphate salt, process for producing the same and use thereof |
| 11/17/2010 | CN101885692A 5-aminolevulinic acid phosphate salt, process for producing the same and use thereof |
| 11/17/2010 | CN101884818A Suction administration system |
| 11/17/2010 | CN101884795A Fluorescent nano probe of nuclease activated type and preparation method thereof |
| 11/17/2010 | CN101884780A Use of hepcidin as a regulator of iron homeostasis |
| 11/17/2010 | CN101370497B Combination product with PARP inhibitors and cell toxin and its uses |
| 11/17/2010 | CN101320607B Preparation method of ferroferric oxide/multi-wall carbon nano-tube magnetic nanometer composite material |
| 11/16/2010 | US7833717 Using neisserial surface protein nucleotide sequences as tool in detection, prevention and treatment of microorganismal infection; immunodiagnostics; immunotherapeutics; vaccine development |
| 11/16/2010 | US7833534 polypeptides and fusion proteins containing immunogenic portion of Leishmania antigens; screening library for tandem repeat immunogenic proteins |
| 11/16/2010 | US7833525 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 11/16/2010 | US7833513 Treatment of Alzheimer's Disease |
| 11/16/2010 | CA2337361C Targeted site specific drug delivery compositions and method of use |